Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ahmad Taftaf
Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
Case Reports in Oncological Medicine
Oncology
Related publications
Chemosaturation With Percutaneous Hepatic Perfusion of Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A Single Center Experience
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
Cancers
Cancer Research
Oncology
Ipilimumab Combined With Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
Clinical Cancer Research
Cancer Research
Oncology
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient With Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
Case Reports in Oncological Medicine
Oncology
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data
Diagnostics
Clinical Biochemistry
Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan
Turk Patoloji Dergisi
Forensic Medicine
Pathology
Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Pcn184 - Cost-Effectiveness of Nivolumab Plus Ipilimumab in Advanced Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
